The Bio Protocol (BIO) price has experienced an impressive surge over the past week, soaring over 80% and reaching its highest point in six months. This rally is fueled by strong whale activity, bullish technical indicators, and real-world biotech application integration through the launch of the new BioAgent, Aubrai. A golden cross on the daily chart suggests sustained bullish momentum. Analysts are now eyeing a potential target of $0.30, which coincides with a significant Fibonacci level. 7-day price gains for BIO stand at over 80%, and its monthly gains reach 175% while year-to-date gains surpass 340%. Whales have been heavily involved in this surge, contributing to the token’s positive sentiment. The shift towards accumulation, evident in a decline in exchange balances, suggests investors are moving tokens into their own wallets, reducing selling pressure and potentially supporting further price growth. However, analysts warn of potential downside risks if BIO prices dip below $0.10, highlighting a possible correction.